Cowen & Co. Reaffirms Their Buy Rating on Amgen Inc (AMGN)

By Austin Angelo

Cowen & Co. analyst Yaron Werber maintained a Buy rating on Amgen Inc (AMGNResearch Report) yesterday and set a price target of $234. The company’s shares opened today at $189.56.

Werber has an average return of 26.3% when recommending Amgen Inc.

According to TipRanks.com, Werber is ranked #383 out of 5203 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Amgen Inc with a $213.08 average price target, representing a 12.4% upside. In a report issued on February 13, Mizuho Securities also assigned a Buy rating to the stock with a $211 price target.

See today’s analyst top recommended stocks >>

Based on Amgen Inc’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $6.2 billion and net profit of $1.93 billion. In comparison, last year the company earned revenue of $5.83 billion and had a GAAP net loss of $4.26 billion.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.